Ozempic is revolutionizing weight loss, with users shedding an average of 11% of their body weight in six months while also reducing the risk of serious health issues. As millions may turn to GLP-1 drugs, the fast food industry could face a staggering decline, potentially losing $18 billion in quarterly revenue. This shift may not only change eating habits but also influence healthcare costs related to obesity and related surgeries.
